But GLP-1 medications such as Ozempic and Wegovy, which have skyrocketed in popularity were not previously offered as part of that program
He helped to found Chiron in 1981 and was later recruited by Steiner to become a professor at the University of Chicago where he became a leading authority on the molecular genetics of diabetes mellitus
Weve had a patient who started at a BMI of 33, and now theyre at a normal BMI of 22, and the insurance is saying, Well, now you have a normal BMI, so youre not covered, Azagury said
You should increase the dose and reassess. The trajectory tends to become clear within the first few weeks, she explained
It is also approved to reduce the risk of major cardiovascular events in adults with obesity or who are overweight with established cardiovascular disease
The bigger picture: GLP-1 insurance coverage trends Understanding the broader insurance landscape helps you anticipate future changes to your coverage and plan accordingly